Dumont, C.M., Carlson, M.A., Munsell, M.K., Ciciriello, A.J., Strnadova, K., Park, J., Cummings, B.J., Anderson, A.J., and Shea, L.D. (2019). Aligned hydrogel tubes guide regeneration following spinal cord injury.Acta Biomater.
Manoukian, O.S., Arul, M.R., Rudraiah, S., Kalajzic, I., and Kumbar, S.G. (2019). Aligned microchannel polymer-nanotube composites for peripheral nerve regeneration: Small molecule drug delivery.J Control Release.
Das, A.Vipin, Donthineni, P.R., Prashanti, S., and Basu, S. (2019). Allergic eye disease in children and adolescents seeking eye care in India: Electronic medical records driven big data analytics report II.Ocul Surf.
Leitão, L., Alves, C.J., Sousa, D.M., Neto, E., Conceição, F., and Lamghari, M. (2019). The alliance between nerve fibers and stem cell populations in bone marrow: life partners in sickness and health.Faseb Jfj201900454R.
Ryu, B., Sekine, H., Homma, J., Kobayashi, T., Kobayashi, E., Kawamata, T., and Shimizu, T. (2019). Allogeneic adipose-derived mesenchymal stem cell sheet that produces neurological improvement with angiogenesis and neurogenesis in a rat stroke model.J Neurosurg1-14.
Shimosato, Y., Tanoshima, R., Tujimoto, S.-I., Takeuchi, M., Shiba, N., Kobayashi, T., and Ito, S. (2019). Allogeneic bone marrow versus peripheral blood stem cell transplantation for hematological malignancies in children: a systematic review and meta-analysis.Biol Blood Marrow Transplant.
Kondo, E., Shimizu-Koresawa, R., Chihara, D., Mizuta, S., Izutsu, K., Ikegame, K., Uchida, N., Fukuda, T., Ichinohe, T., Atsuta, Y., et al. (2019). Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B-cell lymphoma patients relapsing after high dose chemotherapy with autologous stem cell transplantation: data from the Japan Society for Haematopoietic Cell Transplantatio.Br J Haematol.
Granot, N., Storer, B.E., Cooper, J.P., Flowers, M.E., Sandmaier, B.M., and Storb, R. (2019). Allogeneic hematopoietic cell transplantation in the outpatient setting.Biol Blood Marrow Transplant.
Kellner, E.S., Krupski, C., Kuehn, H.Sun, Rosenzweig, S.D., Yoshida, N., Kojima, S., Boutbol, D., Latour, S., Barlogis, V., Galambrun, C., et al. (2019). Allogeneic Hematopoietic Stem Cell Transplant Outcomes for Patients with Dominant-Negative IKFZ1/IKAROS Mutations.J Allergy Clin Immunol.
Pichler, H., Lawitschka, A., Glogova, E., Willasch, A.M., von Luettichau, I., Lehrnbecher, T., Matthes-Martin, S., Lang, P., Bader, P., Sykora, K.W., et al. (2019). Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia - A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWP.Am J Hematol.
Modi, D., Surapaneni, M., Kim, S., Ayash, L., Alavi, A., Ratanatharathorn, V., Deol, A., and Uberti, J.P. (2019). Allogeneic stem cell transplant provides durable response in peripheral T-cell lymphoma.Leuk Res83, 106171.
Shallis, R.M., Gleeson, S., Azar, M., Malinis, M., Xu, M.L., Seropian, S.E., Gowda, L., and Zeidan, A.M. (2019). Allogeneic stem cell transplantation and combination antiretroviral therapy: cautions, complications, and considerations.Leuk Lymphoma1-4.
Ai, J. (2019). Allogeneic Stem Cell Transplantation Following Salvage Inotuzumab Ozogamicin: A Happy Ending?.Biol Blood Marrow Transplant.
Hangai, M., Urayama, K.Y., Tanaka, J., Kato, K., Nishiwaki, S., Koh, K., Noguchi, M., Kato, K., Yoshida, N., Sato, M., et al. (2019). Allogeneic stem cell transplantation for acute lymphoblastic leukemia in adolescents and young adults.Biol Blood Marrow Transplant.
Radujkovic, A., Dietrich, S., Blok, H.-J., Nagler, A., Ayuk, F., Finke, J., Tischer, J., Mayer, J., Koc, Y., Sorà, F., et al. (2019). Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party.Biol Blood Marrow Transplant.
Daghia, G., Zabelina, T., Zeck, G., von Pein, U.-M., Christopeit, M., Wolschke, C., Ayuk, F., and Kröger, N. (2019). Allogeneic stem cell transplantation for myelofibrosis patients aged ≥ 65 years.Eur J Haematol.
Mannina, D., Gagelmann, N., Badbaran, A., Ditschkowski, M., Bogdanov, R., Robin, M., Cassinat, B., Heuser, M., Shahswar, R., Thol, F., et al. (2019). Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL-mutation.Eur J Haematol.
Jaimes-Albornoz, D., Mannone, L., Nguyen-Quoc, S., Chalandon, Y., Chevallier, P., Mohty, M., Meunier, M., Robin, M., Ledoux, M.-P., Guillerm, G., et al. (2019). Allogeneic stem cell transplantation in therapy-related myelodysplasia after autologous transplantation for lymphoma: a retrospective study of the SFGM-TC.Biol Blood Marrow Transplant.
Herrera, A.F., Chen, L., Khajavian, S., Chase, M., Darrah, J., Maloney, D., Ho, V.T., Soiffer, R.J., Antin, J.H., Forman, S.J., et al. (2019). Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B-cell Lymphoma.Biol Blood Marrow Transplant.
Chamoun, K., Milton, D.R., Ledesma, C., Young, K.H., Jabbour, E.J., Alatrash, G., Anderlini, P., Bashir, Q., Ciurea, S.O., Marin, D., et al. (2019). Allogeneic Transplantation after Myeloablative Rituximab/BEAM +/- Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-up Results.Biol Blood Marrow Transplant.
Lachowiez, C., Cook, R.J., Hayes-Lattin, B., Maziarz, R.T., Borate, U., Traer, E., Leonard, J., Newell, L., Dao, K.-H., and Meyers, G. (2019). Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years.Hematol Oncol Stem Cell Ther.
Trevisan, C., Maghin, E., Dedja, A., Caccin, P., de Cesare, N., Franzin, C., Boso, D., Pesce, P., Caicci, F., Boldrin, F., et al. (2019). Allogenic tissue-specific decellularized scaffolds promote long-term muscle innervation and functional recovery in a surgical diaphragmatic hernia model.Acta Biomater.
Wang, H., Hu, Y., He, F., Li, L., Li, P.-P., Deng, Y., Li, F.-S., Wu, K., and He, B.-C. (2019). All-trans retinoic acid and COX-2 cross-talk to regulate BMP9-induced osteogenic differentiation via Wnt/β-catenin in mesenchymal stem cells.Biomed Pharmacother118, 109279.
Luo, Q., Wei, G., Wang, X., Xu, X., Ju, W., Li, Z., Gardiner, E.E., Andrews, R.K., Zeng, L., Xu, K., et al. (2019). All-Trans Retinoic Acid Impairs Platelet Function and Thrombus Formation and Inhibits Protein Kinase CßI/δ Phosphorylation.Thromb Haemost.
Weng, Z., Wang, C., Zhang, C., Xu, J., Chai, Y., Jia, Y., Han, P., and Wen, G. (2019). All-Trans Retinoic Acid Promotes Osteogenic Differentiation and Bone Consolidation in a Rat Distraction Osteogenesis Model.Calcif Tissue Int.